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CHAPTER I 
INTRODUCTION 
The mechanism of action of anesthetics is still unknown 
in spite of extensive studies in this area. Anesthetics act 
in the central nervous system {C.N.S.), by depressing trans-
mission or nerve impulses. There is general agreement that 
anesthetics act nonspecifically and in a physical manner {Goth, 
19?4; Mullins, 19?1). Although anesthetics exert their effects 
on all areas or the nerve cell membrane, the synaptic areas are 
the most sensitive {Larrabee and Pasternak, 1952; Karis, 196?). 
It is not known to what part of the membrane {lipid or protein) 
that anesthetics bind. This will be easier to answer when mem-
brane architecture and its' role in impulse transmission, is 
known beyond hypothetical models. An important region in the 
brain associated with the maintenance of consciousness, is the 
reticular formation. Early studies isolated this region as the 
target or anesthetic action, producing unconsciousness {Moruzzi, 
1949; Davis, 1958; Mori et ~., 1968), but a theory that anes-
thesia is caused by depression of many regions, is rapidly gain-
ing support {Darbinjam ~ !1·, 19?1; Crawford, 19?0; Clark and 
Rosner, 19?J). 
One approach in studying the manner in which anesthetics 
act is to study these drugs in different strains of mice. 
1 
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Different sleep-times between strains or mice have been seen 
frequently, following administration of the C.N.S. depressants 
alcohol and pentobarbital (Jay, 1955; McClearn, 1962; Kakihana 
~ !!·, 1966; Randall and Lester, 1974). Several studies in-
dicate that sleep-time with anesthetics is linearly correlated 
vith brain concentration (Jori et al., 1970; Wollman and Smith, 
1975), and any difference in sleep duration is usually ac-
companied by different metabolic rates of the anesthetic agent 
(Noordhoek, 1968; Belknap et ~., 1972). Some investigators 
though, have discovered sleep-time differences in mouse strains 
(BALB and C57BL) that could only be explained by each strain's 
inborn sensitivity (genetic susceptibility) to the anesthetic 
(Kakihana et !!·, 1966; Randall and Lester, 1974). From this 
work, the question arose whether or not BALB and C57BL mice 
would demonstrate contrasting sensitivities to a volatile anes-
thetic; and if so, would the results be similar to previous 
studies with alcohol, or barbiturate depressants? The following 
study is intended to answer these questions. Sleep-times or 
C57BL and BALB/C strains of mice have been determined using 
methoxyflurane, a volatile anesthetic. Brain and blood levels 
or methoxyflurane have been measured and correlated with sleeP-
time to determine strain sensitivity. 
CHAPTER II 
REVIEW OF LITERATURE 
Strain Differences 
Central nervous system sensitivities to C.N.S. depressants 
have been studied by observing sleep-time, a behavioral re-
sponse. Mice have most frequently served as the test animal 
of choice. Generally, sleep-time response between different 
strains of mice seem to correspond to brain levels and metabo-
lic rates or the anesthetic agent (Tabakotf and Erwin, 1971; 
Noordhoek, 1968). These results conform to accepted concepts 
of anesthetic action - however, some investigations have shown 
results to the contrary (Introduction). Ethyl alcohol has in-
duced a 3-told sleep-time difference between mice strains or 
BALB/C and C57BL. The C57BL strain was round to have shorter 
sleep-times accompanied with greater brain and blood levels 
(Kakihana et !l·• 1966). The C57BL strain is known to possess 
a higher liver alcohol dehydrogenase level than the BALB/C strain 
(Schlesinger, 1966), but 1n ~rates or alcohol metabolism 
are the same (Kakihana, 1966). Randall and Lester (1974}, 
studied central nervous system sensitivities to pentobarbital 
and ethyl alcohol, with mice strains BALB/CJ and C57BL/6J. They 
round that ethyl alcohol caused a 2-fold difference ~n sleep-
time - with the BALB/CJ strain sleeping longer. These differences 
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are not attributed to the greater alcohol dehydrogenase levels 
round in C57BL's (Kakihana, 1966). An opposite effect was seen 
with pentobarbital. The sleep-times were equal but the BALB/CJ 
strain had greater barbiturate brain and blood levels upon 
awakening- rendering it less sensitive. 
Characteristics Of General Anesthetics 
The physicochemical aspects of the action of anesthetics 
have been studied and there is general agreement that no chemi-
cal reaction is responsible tor anesthesia (Bennett, 1969; 
Mullins, 1971). 
Three theories commonly explain the physical actions of 
anesthetics. These theories involve the action of anesthetic 
agent with lipid, protein, and water structure. Pauling, 1961; 
Miller, 1961, separately claimed that inhalation anesthetics 
form hydrated microcrystals within the central nervous system. 
This involves a structural arrangement of the molecules of the 
anesthetic with water molecules. Pauling stated that the re-
sultant microcrystals (•clathrates 11 ) forming in the synaptic 
regions of the brain, interfere with the neural network, causing 
a decreased energy of electric oscillations. Miller's account 
is more specific as he stated that the microcrystals (•icebergs•) 
cause narcosis by lowering conductance, through stiffening or 
plugging up of the nerve cell membrane. Both theories are weak 
in that the microcrystals are not stable at either body temperature 
or at atmospheric pressure. Further, such anesthetics as ethyl 
s 
ether, halothane, and methoxyflurane, do not form microcrystals 
(Nunn, 1972). Pauling defends the theory by noting that 1 clath-
rates" are stabilized by charged side chains of proteins or 
Q.N.S. solutes. 
The potency of inhalation anesthetics is proportional to 
their lipid solubility. This relation is thought to be much 
closer than a capacity of these agents to function as modifiers 
of water structure (Eger et !!·, 1969). Studies with the noble 
gases demonstrate an excellent correlation between lipid solu-
bility and narcotic potency (Bennett, 1969). A wide variety of 
inhalation anesthetics also show excellent correlations between 
their potency and their oil/gas coefficients (Eger ~ Al·· 1969). 
However, alkaloids and inorganic ions do not comply with the 
theory and many f~t soluble substances have no depressant action 
or actually produce convulsions (Krantz !1 !!·• 1958). The 
difficulty with the lipid solubility/anesthetic potency correla-
tion is that it offers no real explanation for the mechanism or 
anesthetic action. 
Experiments with cell membranes support a membrane protein 
site of action. Nitrous oxide and chloroform have both been 
round to increase the lateral pressure of lipoprotein films 
(Clements,l962). He speculates that similar actions may be seen 
with nerve cell membranes during anesthesia. 
Burgen (1971) demonstrated with red blood cells that there 
is strong binding of anesthetic to membrane protein, and that 
the concentration of anesthetic in membrane protein appears to 
exceed the concentration in membrane lipid. 
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Seeman and Roth (1972) demonstrated that clinical concen-
trations or anesthetics protected (8.0 %) red blood cells 
against hypotonic hemolysis. This protection is thought to be 
due to a 0.4% expansion of the cell membrane (Seeman !1 !!•, 
1969). Other studies have shown that this 0.4% expansion is 
associated with a 0.02% or less, increase in volume or the 
anesthetic in the membrane (Seeman, 1972; Seeman and Roth, 1972). 
Since membrane expansion is roughly 20 times the occupying volume 
or the drug in the membrane phase, it has been suggested that 
extensive conformational changes in membrane proteins may be 
involved (Seeman, 1972). 
Mullins (1971) and Nunn (1972) have both postulated the-
ories which state that ion pores in the nerve cell membrane, 
are affected during anesthesia. Mullins reasoned that anesthe-
tics may directly block ion pores (channels) in the membrane. 
His theory states that the size of the anesthetic molecule is 
an important parameter in the blocking of the membrane pore. 
Decane is lipid soluble but it is not an anesthetic. Mullins 
would explain this by saying that decane is too large to fit 
into the membrane pore. The molecular attraction of anesthetic 
in the membrane pore is thought to be the result or electrosta-
tic attraction of dipole (Vander Waal's intramolecular force). 
Nunn's theor.y is slightly different. He theorized that anesthe-
tics produce effects by interaction with proteins in the nerve 
cell membrane, He feels that this interaction can produce con-
formational changes sufficient to alter the property or proteins. 
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This action could interfere with nerve cell membrane pores. 
Nunn•s literature review points out that anesthetics are highly 
selective for different proteins and that this selectivity ac-
counts for different actions of anesthetics. He notes that 
trichloroethylene, nitrous oxide, and methoxyflurane are anal-
gesic in subanesthetic doses, while halothane is not. Nunn•s 
theory accounts for this difference of action as due to unique 
binding sites {proteins) of these anesthetics. 
Nerve cell membranes are thought to be altered by anes-
thetics, in some way, to affect depolarization by impeding 
transmembrane fluxes of ions. Anderson and Amaranath (1973) 
took a comprehensive look at experimental evidence or anesthe-
tic effects on transport across cell membranes. They concluded 
that anesthetics uniformly affect transmembrane fluxes, and that 
all agents producing general anesthesia, including the charged 
forms of local anesthetics, act thru a single basic mechanism 
of action, a nonspecific physical effect in the membrane. In 
their conclusion they say, "it is theoretically possible that 
anesthetics affect transmembrane fluxes by modification or con-
formational changes in membrane proteins.• 
Gergis ~1 !!·, 1972 measured acetylcholine concentrations 
released at synaptic junctions during anesthesia. They found 
that although the anesthetics depressed nerve transmission, the 
acetylcholine volumes remained unchanged when compared to the 
period just before anesthetic application. This work discou-
rages earlier theories that synaptic vesicle membranes are 
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affected. 
Research has shown that the synaptic junction 1s the 
most sensitive area of the neuron to anesthetics. Using pla-
tinum electrodes, Larrabee and Pasternak (1952) studied the 
effects of sodium pentobarbital, on synaptic transmission and 
axon conduction. They round that the anesthetic had a greater 
depression effect on synaptic transmission than on axon con-
duction. Karls (1967) supported these conclusions with work he 
did with neuromuscular responses to blocking concentrations of 
di-ethyl ether. 
In 1947, studies of lesions in the reticular formation of 
the cat by Lindsley, Bonden, and Magoun, showed a persistent 
sleep pattern on the electroencephalogram which could not be 
activated by peripheral stimuli. Many studies have emerged 
from this work to demonstrate that the reticular formation is 
the most important brain region depressed during general anes-
thesia. 
Stimulation of the reticular formation system 1n sleeping 
cats, resulted in a change in the electroencephalogram from the 
sleeping pattern to the awake pattern (Moruzzi, 1949). Ether 
and pentobarbital selectively depressed the multiple unit ac-
tivity of the reticular formation, and stopped electroencepha-
lographic arousal produced by reticular stimulation (French, 
195J). Later studies with animals have shown that commonly used 
general anesthetic agents exert their initial effect in the re-
ticular activating system, before acting upon other areas of 
the brain (Davis, 1957; Davis, 1958). Mori, Winters, and Spooner 
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(1968) experimented with cats using di-ethyl ether, halothane, 
and pentobarbital to study multiple unit activity with auditory 
evoked responses. They found that the spontaneous activity in 
the reticular formation decreased progressively with increased 
doses of anesthetic. 
Traditionally, the brain stem reticular formation has 
been accepted as the main target of anesthetic action causing 
unconsciousness - however, research is mounting to support a 
multi-site theory of action. Ether anesthesia abolishes the 
impulse resulting from an auditory stimulus somewhere in its 
route thru the reticular formation, but does not block the dir-
ect pathway via the lateral lerninscus (French et al., 1953). 
Similarly, nitrous oxide, ethylene, and cyclopropane primarily 
decrease responses evoked from the reticular activating system 
(tested by stimulation of the radial nerve), but these agents 
also reduce the direct response in the thalamus by up to 50 per-
cent (Davis et al., 1957). The effects of thialbarbital and 
di-ethyl ether on the reticular formation and cerebral cortex 
were studied in the cat. Both anesthetics had different de-
pressant effects on the brain. Thialbarbital caused marked de-
pression on cortical activity. Inhalation of ether depressed 
the cerebral cortex but it also showed early depression of sy-
naptic input to the reticular formation - however, the functional 
state of the reticular formation was not altered (Darbinjam ~ 
al., 1971). Cortical neuron sensitivity to acetylcholine, and 
an amino acid excitant (DL-homocysteic acid), was studied in 
oats with barbiturate and inhalation anesthetic agents. 
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Barbiturates were found to depress this sensitivity to cortical 
neurone in doses lees than used in surgical anesthesia. Halo-
thane at 1.5 percent depressed excitability, but methoxyflurane 
was found not to alter chemical excitability of cortical neurone 
- even at anesthetic levels. These findings indicate that 
neurons in the cerebral cortex differ in their susceptibility 
(sensitivity) to different anesthetic agents {Crawford, 1970). 
Clark and Rosner (1973) discovered that in man the electroen-
cephalographic effects of methoxyflurane, halothane, and chloro-
form are similar to each other, but are distinctly different 
from those of ether, nitrous oxide, and cyclopropane. This work 
suggests that even similar anesthetics {inhalation anesthetics) 
may have different regional sites of action. Randall and Lester 
(1974) found different C.N.S. sensitivities of two strains of 
mice (C57BL/6J and BALB/CJ) to alcohol and pentobarbital. 
Sensitivities to the two drugs were determined by making com-
parisons of sleep-time with brain and blood anesthetic concen-
trations. The differences of c.N.S. sensitivity could not be 
attributed to any metabolic differences or the drugs between the 
two strains. The results of these studies suggest that anesthe-
tics act at more than one region in the central nervous system. 
Quastel and Wheatly (1932) postulated that anesthesia re-
sults from depression or cerebral respiration. However, exces-
sive anesthetic concentrations often are required to inhibit 
respiration in isolated tissue preparations (Quastel, 1965). 
It has been suggested that the overall brain oxygen consumption 
might fail to reveal profound inhibition in vital local areas. 
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In support of this notion a small number of cells in fish retina 
called Mcontroller cells" respond within seconds to anoxia or 
hypercapnia caused by alcohols and several volatile anesthetics 
(Negish1 and Svaetichin, 1966). If Mcontroller cells" exist in 
the central nervous system, and they modify the activity of other 
cells, then anesthesia might inhibit the metabolism and action of 
these "controller cellsu without affecting the total brain 
metabolism. 
Ill vitro studies of brain carbohydrate metabolism suggest 
that anesthetics inhibit electron transport between cytochrome 
oxidase and a flavoprotein concerned with the oxidation of reduced 
nicotine adenine dinucleotide (NADH) (Quastel, 1965). Since oxi-
dation of NADH allows phosphorylation of adenosine diphosphate 
(ADP) to adenosine triphosphate (ATP), it follows that anesthetics 
might inhibit oxidative phosphorylation. However, suppression of 
ATP formation may result from lowered utilization of ATP. Since 
ATP inhibits its own synthesis, lowered utilization would dis-
courage further formation, and suppression of formation therefore 
would not necessarily prove a direct effect of the anesthetic. 
Also, the !n !1!Q concentration of brain ATP is unchanged during 
anesthesia, which suggest that this is not the cause of anesthesia 
(Michenfelder et al., 1970). 
If anesthetics act by inhibiting metabolism, then a likely 
site of action is the mitochondria. Major functions of mito-
chondria include those of energy transfer and storage. As noted 
previously, cerebral ATP levels do not decrease as a result of 
anesthesia (Michenfelder et al., 1970). 
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All the enzymatic theories of anesthesia leave one question 
unanswered - that is, are effects observed the cause or result 
of anesthesia? In other words, do enzymatic changes cause 1n-
h1b1t1on of synaptic transmission, or are they themselves caused 
by the general depression of the nervous system? 
Characteristics Of Methoxyflurane 
Physical Properties: 
Methoxyflurane (2,2-d1chloro-l,l-d1flouroethyl methyl 
ether) was first synthesized in 1958, and it was first used 
clinically in 1960, by Artus1o et !1· Methoxyflurane has the 
structural formula: 
Cl F H 
I I I 
H - C - C - 0 - C - H 
I I I 
Cl F H 
Physical constants or methoxyflurane (Abbott Laboratories) are: 
Molecular weight •...•••••.•.•.....•••.•.•.•• 164.97 
Bolling point at 760 mm. Hg ••••••••••••·•••• 104.65° C. 
Partition coefficient at 37° C. 
water/gas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4. 5 
blood/ gas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10. 2 
oil/ gas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 825.0 
Vapor pl"8ssure • • • . . • . . . . . . . . . . . . . . . . . . . . . . • • 20 mm. Hg 
Flash points 
in air ................................. . 
in oxygen (closed system) •••.•.......••• 
in nitrous oxide 50% with 50% oxygen •••• 
Lower limits of flammability of vapor 
con centra tiona 
1n a 1r .................................. . 
1n oxygen ............................... . 
1n N2o .50,% •••••.••.•..••••.•••.•......••. 
Methoxyflurane is the first clinically useful nonex-
plosive ether to be found. Many of its' pharmacologic proper-
ties are similar to those of other halogenated hydrocarbons. 
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Pharmacology: 
Knox and colleagues (1962), using gas chromatography, 
determined the vapor concentrations necessary to induce and 
maintain anesthesia in humans. During induction an excess or one 
percent is required for surgical anesthesia. An inhaled con-
centration of 0.2 to 0.5 percent is needed for anesthesia 
maintenance. 
During anesthesia, adipose tissues continue to absorb 
methoxyflurane. In subcutaneous fat the level of methoxyflurane 
(3.4 mg./g.) plateaued after five hours of administration at 
1.0%. In the postanesthetic period, the brain was found to 
have the second highest tissue concentration - second only to 
the suprarenal gland. This information was obtained using dogs. 
Deep levels or anesthesia were associated with methoxyflurane 
levels of 0.51 milligram per milliliter of venous blood and 0.72 
milligram per milliliter was found in venous blood when the dogs 
had regained consciousness. No brain levels were measured at 
this time (Chenoweth~~., 1962). 
Methoxyflurane is mostly eliminated by the lungs. Species 
differences occur however in the amount that is metabolized. 
Van Dyke et ~., (1964) detected that rats exhaled 85-90 percent 
or methoxyflurane within 30 hours after injection. Labeled 
chloride in concentrations of 1.1 percent were found in urine 
within 48 hours after anesthetic injection. They reported that 
the majority or rats yielded a 1-2 percent conversion or methoxy-
flurane. Degradation of 20 to 50 percent are reported to occur 
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in man (Cohen, 1971; Halsey,~ !!·• 1971). 
The respiratory center of the central nervous system is 
greatly affected by methoxyflurane. Respiratory depression is 
directly related to the depth of anesthesia. Respiratory para-
lysis is easily produced and for this reason methoxyflurane is 
commonly administered thru an endotracheal tube to control vital 
respiration (Price, H.L., 1975). 
Methoxyflurane creates a blood pressure fall that is pro-
portional to the depth of anesthesia. This hypotension is 
accompanied by bradycardia, reduced cardiac output, and reduced 
contractile force of the heart {Wood-Smith et !!•, 1973; Price, 
1975). 
At relatively light planes of anesthesia, methoxyflurane 
provided substantial analgesia and muscular relaxation. Anal-
gesia may even persist after consciousness has returned. Skele-
tal muscular relaxation is profound at deep levels of anesthesia, 
but so are the circulatory affects; for this reason, neuromus-
cular blocking drugs are usually used to achieve muscle relax-
ation (Price, 1975). 
Methoxyflurane is not believed to have any specific toxic 
effects on the liver - however, a few cases of liver necrosis 
have been seen after anesthesia (Wood-Smith et !l·, 1973). 
Renal dysfunction associated with methoxyflurane is rare 
but high output renal failure has been observed. This syn-
drome is characterized by: dilute urine, dehydration, and 
azotemia (Mazze et !1•, 1971). 
CHAPTER III 
METHODS 
The animals for this study consisted of 21 male BALB/C 
and 21 male C57BL mice, 10-13 weeks of age, weighing 22-30 
grams. The mice were maintained on Purina Lab Chow and tap 
water ad libitum. They were kept in an artifically lighted 
vivarium for ten days before each test began. All experiments 
were started at 1:00 p.m. (± 30 minutes), to avoid circadian 
variation (Speciale and Friedman, 1971). 
This study consisted of three experiments. In the first 
experiment, pain-pressure and righting reflex recoveries were 
recorded and were compared with brain and blood methoxyflurane 
extractions taken immediately after righting reflex recovery. 
The second experiment was concerned with righting reflex re-
covery only. In experiment three, the brain and blood methoxy-
flurane extractions were performed immediately after the mice 
were taken out of the anesthesia flask. A measurement of fall-
time was also recorded (see experiment III for definition). 
Experiment I. Part A 
Ten pairs of mice were anesthesized separately in two 
500 milliliter Erlenmeyer flasks, using a semi-closed system. 
A flow chart of this system is diagramed on the following page. 
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----------X-----------X---------X---------X X------X------X 
----------X-----------
Oxygen Vaporizer Holding Anesthesia Y-Tube Water Vent 
tank tank flasks trap 
The purpose of the water trap is to keep out environmental air. 
One mouse from each strain was placed in the anesthesia 
flasks. The flasks were alternated so that each strain had the 
same flask every other test. Each mouse was subjected to me-
thoxyflurane via a vaporizer for 35 minutes. Initially, the 
vaporizer was set at 1.5 percent, with an oxygen flow rate or 
4.0 liters per minute, for 25 minutes. Anesthesia was main-
tained with the vaporizer set at 0.5 percent, with an oxygen 
flow rate of 1.0 liter per minute, for 10 minutes. 
Experiment I. Part B 
At the end of the 10 minute anesthesia maintenance 
period, the mice were taken out of the anesthesia flask and 
were placed on their backs. Pain-pressure responses and right-
ing reflex recovery were then recorded as measurements of sleep-
time. The time lapse, from placing the mice on their backs 
until they responded to pain (by pinching their tails) was re-
corded as pain-pressure recovery. The response took the form 
of limb or abdominal movement caused by the pinch. The tails 
were pinched half way up at six second intervals. After the 
. 
pain-pressure response was elicited, the pinching vas con-
tinued (at thirty second intervals) until their righting re-
flex was recovered. Righting reflex recovery was measured as 
the time lapse from placing the mice on their backs until they 
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rolled over twice within one minute. 
Experiment I. Part C 
Preparation for assaying the concentrations of anesthe-
tic in brain and blood were initiated immediately after each 
mouse had regained its• righting reflex. The mice were sacri-
ficed by cervical dislocation. This was achieved by sharply 
pulling the tail while pressing a probe against the posterior 
portion or the first few cervical vertebrae. Blood samples 
or approximately 20 microliters were collected in heparized 
glass capillary tubes. This was done bw exposing and removing 
the heart, and by plunging the capillary tube in and out or the 
pooled blood in the mediastium. The tubes were sealed at both 
ends with clay. Three samples were taken simultaneously ror 
each strain. The brains were then removed and were placed in 
J.O milliliter glass vials which contained 1.5 milliliters or 
extracting solution and 7 glass beads. The vials were topped 
with aluminum roil. A rubber septum was placed on top or the 
foil and was pressed down the vial 1/8 inch to complete the seal-
ing. The brain weight vas then recorded. This was determined 
by subtracting the weight or the vial (extracting sol., glass 
beads, foil, septum) before and after the addition or the brain. 
The brains were then broken up on a Vortex mixer for 12 minutes. 
Further mixing and anesthetic extraction was performed with a 
mechanical mixer ror 10 minutes. The homogenized brains were 
then centrifuged for 15 minutes, at JOOO r.p.m. The centrifuge 
separated the homogenate into a cellular and a clear layer. 
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The methoxyflurane was localized in the clear layer at the top 
of the vial. The clear layer was then transfered by a glass 
syringe into a 1.0 milliliter glass vial. The vial was sealed 
with a teflon lined twist-cap. Both blood and brain extractions 
were then ready to be assayed by gas chromatography. 
~periment II. Part A 
Eleven pairs of mice were anesthesized under a 10.5 liter 
Bell Jar. A flow chart of this system is diagramed below. 
X---------X----------X---------X---------X---------X 
Oxygen : Vaporizer : Holding : Bell jar : Water : To Vent 
tank trap 
The Bell jar was divided by a hollow plywood partition which 
separated the space into equal volumes. The Bell jar sat on 
a 2 1 x2 1 plywood base which was covered with a towel. The 
methoxyflurane entered the jar via glass tubes which passed thru 
the base and were located between the partition. Five mice from 
each strain were placed on opposite sides or the plywood wall. 
The mice were subjected to methoxyflurane for 45 minutes. Dur-
ing the first 8 minutes the vaporizer was set at 1.5 percent 
with an oxygen flow rate of 5.0 liters per minute. The oxygen 
flow was then cut to 1.0 liter per minute - with the vaporizer 
remaining at 1.5 percent, for 22 minutes. Anesthesia was main-
tained at 0.5 percent, with an oxygen flow rate or 1.0 liter 
per minute, for 15 minutes. 
Experiment II. Part B 
At the end of the 15 minute anesthesia maintenance period, 
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the mice were taken out of the Bell jar and were placed on 
their backs. The time lapse from placing the mice on their backs 
until they rolled over twice within one minute, was recorded as 
righting reflex recovery. 
Experiment III. Part A 
The mice that were tested in Exp. II were given a ten day 
rest period, prior to being used in Exp. III. The administra-
tion of methoxyflurane (technique and apparatus) was the same 
as that used in experiment I. 
Experiment III. Part B 
A measurement of fall-time was made for each strain. Fall-
time is a measurement of time lapse from when the anesthetic is 
turned on, until the mouse falls and can not otter resistance to 
being positioned on ita• back. The mice were positioned on 
their backs (rolled over) by gently shaking the anesthesia flask. 
Experiment III. Part C 
The extraction of methoxyflurane from blood and brain was 
executed as soon as the mice were taken out of the anesthesia 
flasks. A blood sample (45·7 ul.) approximately half of one 
heparized capillary tube, was collected from the mediastium in 
the same manner as stated in Experiment I. Part C. The blood 
was then transfered to a three milliliter glass vial which was 
precooled in an ice bath, and contained ?8.0 ul. of extracting 
solution (see materials). The blood was then mixed in the ex-
tracting solution thru vigorous stirring with a capillary tube. 
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The blood mixture was left in the ice bath so that the anesthe-
tic extraction of the brain could be started with no further 
delay. The brain anesthetic extractions were handled in the 
same manner as described in Experiment I. Part c. After the 
brains were sealed in the glass vial, attention was again di-
rected to the blood extraction. One capillary tube for each 
strain was filled with the blood mixture and was sealed at both 
ends with clay. The tubes were then centrifuged in a micro-
capillary centrifuge for 8 minutes. A cellular, plasma, and 
clear layer (extraction sol.) resulted, with the methoxyflurane 
captured in the clear layer. The clear layer was separated 
from the other two layers by breaking and sealing the capillary 
tube at the plasma/extracting solution border. The blood anes-
thetic extraction was now complete. The brains were then weighed, 
homogenized, and centrifuged as described in Experiment I. Part 
C. The extracted methoxyflurane was transfered via a glass 
syringe into a 1.0 milliliter glass vial, and was capped with a 
teflon lined twist-cap. 
This method of anesthetic extraction from brain and blood 
is adapted from those used by Wolfson et al., 1966; Cervenko, 
1968. Modification came in the choice or toluene as the anes-
thetic solvent. Prior studies (Chenoweth!! !l·, 1962; Allott 
et ~ •• 1971) used carbon disulph1de as the solvent. Carbon 
disulphide is not an ideal solvent because of toxicity, effects 
on the chromatograph base line, and plugging effects on the chro-
matograph column and detector. In addition, other solvents 
which were tried, such as heptane and carbon tetrachloride, both 
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elute from the column at the same time as methoxyflurane, 
thus precluding their use. Toluene was found to be a good 
solvent in that it separated from methoxyflurane cleanly, it 
is relatively nontoxic, and it has no clogging effect on the 
chromatograph. The only drawback in using toluene is that it 
takes a relatively long time (15 minutes) for it to clear thru 
the column. 
E~periment I. & III. Measurement of methoXYflurane in brain 
and blood. 
Gas chromatography is a commonly used method for the 
measurement of inhalation anesthetics. The chromatograph is 
comprised of an analytical column, a detector, and a recorder. 
The sample to be analyzed is injected into a heated port where 
it is volatilized. It is then carried by an inert gas (nitrogen) 
thru the column to the detector. The column contains different 
substances which adsorb the various volatilized components for 
different lengths of time. Multiple components thus reach the 
detector separately. The detector sends a signal to the re-
corder, for each component, varying in intensity, according to 
the quantity present. The recorder displays the signal in the 
form of a peak. The area under this peak gives an accurate in-
dication of the quantity present. When the peaks are sharply 
defined with a narrow base, it is acceptable to use the height 
of the peak for quantity determination (Burchfield and Storrs, 
1962). 
The analyses were performed on a Hewlett/Packard model 
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5750-B gas chromatograph {G.C.)- equipped with a hydrogen 
flame detector. The column consisted of a 6 foot by 1/8 inch 
coiled brass tube, and was packed with 5% SE 30 on 60-80 Chro-
mosorb W. Settings for the brain and blood samples for ex-
periment I were as follows: Brain: column temperature 100° C., 
carrier gas flow (N2 - 39 p.s.i. at 20 rnl./min.) at setting 1.0, 
range 10, attenuation 16, paper speed 0.5 inch a minute; Blood: 
column temperature 90° c., carrier gas flow (N2- 39 p.s.i. at 
30 ml./min.) at setting 1.5, range 10, attenuation 16, paper 
speed 0.5 inch a minute. Oxygen (30 p.s.i.) was burned with 
the hydrogen (10 p.s.i.) during all assays. The G.c. settings 
for the brain and blood assays in experiment III were the same 
as the brain settings for experiment I. 
Dose response and internal standard techniques were em-
ployed to determine the anesthetic concentrations. The dose 
response method was used for the blood assays. In experiment 
I, the gas chromatograph was calibrated by injecting different 
dilutions of known amounts of methoxyflurane disolved in water. 
A response to 40 and 20 milligram percent dilutions was attained 
before and after each blood assay (fig. I). In experiment III, 
dose responses were attained with a 10 milligram percent solu-
tion (see materials). The calibrating solutions were made up 
fresh every three days. Blood anesthetic concentrations were 
determined by comparing the unknown peak heights to the known 
(mg./ml.) peak heights. 
The internal standard technique (detailed by Burchfield 
et ~., 1962) was employed for determining the brain quantities 
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ot anesthetic. This technique was used in both experiments 
(I & III). Toluene, (extracting solvent) di-ethyl ether, 
(internal standard) and a precisely known amount of methoxy-
flurane (10 mg. %), comprised the calibrating solution {see 
materials for amounts). The calibrating solution was made up 
fresh every three days. The calibrating solution functioned by 
displaying peak ratios of methoxyflurane to di-ethyl ether, with 
a known amount of methoxyflurane (fig. 2). The unknown methoxy-
flurane is thus determined by dividing the known ratio by the 
unknown ratio and by multiplying the quotient by the known milli-
gram quantity of methoxyflurane in the calibrating solution. 
This yields the total milligram amount extracted. This number 
is then multiplied by the ratio 1000 mg./brain wt. This will 
give the amount in mg. of methoxyflurane extracted, contained 
in 1.0 gram of brain. This formula is represented below: 
Ratio from cal. sol. X Mg. amount of anesthetic X 1000 mg. 
Ratio from unknown in the cal. sol. mg. brain wt. 
Blood samples were assayed by breaking the capillar.y 
tubes. drawing the blood (Exp. I) or extracting solution (Exp. 
III) with a 1.0 microliter syringe, and injecting it directly 
into the gas chromatograph. Three injections of o.5 microliter 
amounts were assayed for each blood and brain assay. The mean 
value of the three injections was recorded as the quantity of 
anesthetic present. 
Statistical analysis 
Comparisons of the sleep-time evaluations, and blood and 
brain anesthetic concentrations between the two strains (BALB/C 
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and C57BL) were made by using analysis of variance. 
CHAPTER IV 
RESULTS 
The results or experiment I are presented in tables I -
VII (pages 27- Jl). Significant sleep-time differences were 
found between BALB/C and C57BL strains of mice. With both 
measurements or sleep duration the C57BL mice slept longer than 
the BALB/C mice- pain-pressure (F- 12.2, dt- 1/18, P<.OOS) 
and righting reflex (F- 11.1, df- 1/18, p<.oos). When com-
paring the mean differences between the two sleep-times, it 
was found that pain-pressure (53%) showed a 18% greater dif-
ference than the righting reflex evaluation (35%). This may 
indicate that the pain-pressure test is a more sensitive test, 
when measuring recovery, than the righting reflex method. De-
spite these sleep-time differences, no significant contrast was 
detected in either blood or brain anesthetic concentrations, 
extracted immediately after righting reflex recover,y. A comment 
should be made about the reliability of the blood data. The 
procedure of injecting blood samples straight into the chroma-
tograph is not a good one, as it yields variable results be-
tween injections. The average standard deviation, of the three 
injections, in all the mice, was 0.12 milligram. This is fairly 
high when considering that the mean of the whole test was 0.24 
milligram. Even with the great variability, the data was still 
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in agreement with blood methoxyfluraile recovery levels reported 
with doge (Chenoweth et al., 1962). No report of such varia-
bility was made in this publication. Another unfavorable 
characteristic of the procedure was that the syringe and G.CJ. 
injection port both frequently needed to be cleared of drieCi 
blood. Because of these liabilities, a different procedure was 
used for blood extractions in experiment III. 
The results of experiment II are displayed in tables VI II 
-X (pages 32- 34). The sleep-times in experiment II were ~n 
the same direction as those found in experiment I. The C5713L 1 s 
slept 44.% longer than: the BALB/C' s. Because of the greater 1ength 
ot anesthetic time, both strains slept almost twice as long as 
in experiment I. 
The results of experiment III are found in tables XI -- JCVI 
(pages 35- 40). No tall-time differences were detected be--
tween the two strains. No anesthetic (blood or brain) differ-
ences, extracted at the greatest depth of anesthesia, were seen 
either. These results indicate that the mice received equalL 
amounts of methoxyflurane which was absorbed and distributed. at 
similar rates. The procedure tor blood extraction and analys.:1..s 
in experiment III were far superior to those used in experirnen t 
I (see figures III and IV). The average deviation, between t~e 
three injections, of all the mice, was 0.04 milligram. Thiet 
is very acceptable when considering that the mean for the wb.o1e 
study was 1. 50 milligrams. Also, the problem of dried blooc1 .1.n 
the syringe and injection port was eliminated, which decreae.ed 
the time and labor of assaying the samples. 
TABLES 
TABLE I. Sleep-time duration beginning at the end of the 
anesthesia maintenance period. 
SLEEP-TIME 
PAIN-PRESSURE RIGHTING REFLEX 
~in minutes~ ~in minutes~ 
C~ZBL BALBLC CSZBL BALBLC 
5.1 5-0 21.4 20.9 
8.5 2·5 46.8 15.1 
4.0 2-5 19-3 12.3 
9-0 7-0 25·5 24.0 
6.7 2.9 22·3 15·7 
16.4 4.3 32.4 22.8 
10.7 5·5 28.8 18.2 11.4 4·5 28.6 12.0 7-0 .o 23.0 16.7 
12.0 5.8 28.0 23·2 
TABLE II. Anesthetic concentration extracted at the time 
of righting reflex recovery. 
ANESTHETIC CONCENTRATION 
BLOOD BRAIN 
~ mg. L1. 0 ml. ) ~mg.Ll.o g.~ 
C5ZBL BALBLC C5ZBL BALBLC 
.20 • 21 .28 • 28 
.12 .15 .12 • 20 
.21 • 20 .22 • 26 
.24 • 30 .22 .24 
.;..;. • 34 .25 .24 
·23 ·29 .17 • 26 
.19 
•40 .27 -25 
·31 • 2 .21 -30 
.13 ·30 .15 .19 
-28 ·23 .20 .15 
.;..;. Technical problem 
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TABLE III. Analysis of Variance Table, applied to sleep-time duration beginning at 
the end or the anesthesia maintenance period. 
PAIN-PRESSURE 
Variance DF ss MS F PROBABILITY 
SOU.r.2!, 
-
Between 1 114.24 114.24 12.19 .001 > p > .oos N 
(X) 
Within 18 168.73 9·37 
RIGHTING REFLEX 
Variance DF ss MS F PROBABILITY 
• 
SOJ:U:2!, 
- -
Between 1 453.15 453.15 11.10 .001 > p > .oos 
Within 18 ?33.60 40.?5 
TABLE IV. Analysis of Variance Table, applied to anesthetic concentration extracted 
at the time of righting reflex recover,y. 
BLOOD ASSAY 
Variance DF ss MS F PROBABILITY 
So~ 
- -
Between 1 500.10 500.10 6.4 .05 >P >•10 
N 
1:324.70 
'-.0 
Within 17 77.90 
BRAIN ASSAY 
Variance DF sa MS F PROBABILITY 
Source 
-
Between 1 17.10 17.10 1.6 .10 > p > • 25 
Within 18 198.70 11.00 
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TABLE V. Statistics applied to sleep-time duration begin-
ning at the end of the anesthesia maintenance period. 
SLEEP-TIME 
Range 
Mean 
Standard 
Deviation 
Alpha Error 
PAIN-PRESSURE 
(in minutes) 
C57BL 
4.0-16.4 
9.1 
BALB/C 
2· 5-7.0 
4.J 
.001 > p t> .005 
RIGHTING REFLEX 
(in minutes) 
C57BL BALB/C 
19-J-46.8 12.0-24.0 
27.6 18.1 
7·9 4.5 
.001 > p > .005 
TABLE VI. Statistics applied to anesthetic concentration 
extracted at the time or righting reflex recovery. 
ANESTHETIC BLOOD ASSAY BRAIN ASSAY 
CONCENTRATION ~mg.Ll.O ml. ~ ~ mg. L1. 0 g. ) 
CSZBL BALBLC CSZBL BALBLC 
Range .12-.Jl .15-.42 .17-.28 .15-.30 
Mean • 21 • 27 .19 .22 
Standard 
Deviation .06 .08 .05 .05 
Alpha Error .05 >P > .10 .10 >P > .25 
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TABLE VII. Animal weight, brain weight, and methoxyflurane 
levels extracted per whole brain. 
Animal wei~ht Brain weight Anesthetic extracted {in grams (in milligrams} (in milligrams) 
C57BL BALB/C C57!!L BALBLC C57BL BALB/C 
24.0 .30.0 ·.324 ·379 .091 .106 
24.0 29-0 ·270 .264 .032 .0,5.3 
22.0 28.0 .220 .229 .048 .059 
22.0 .30.0 • 250 .250 .055 .060 
25.0 27.0 • 2.30 .250 .0~7 .060 22.0 27.0 • 27.3 
.2,0 .o 6 .065 22.0 26.0 • 210 .2 7 .057 .062 
2.3.0 27.0 • 270 .22.5 .0.57 .068 
22.0 28.0 • .376 ·.39.3 .056 .075 
~ Z2.:.Q ~ .!.li2 .&lZ ~ 
Mean 2.3.0 28.0 .271 .288 .0,56 .067 
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TABLE VIII. SleeP-time duration beginning at the end of the 
anesthesia maintenance period. 
SLEEP-TIME 
RIGHTING REFLEX (in minutes) 
C57BL BALB/C 
14.5 16.8 
50.8 18.3 
65.8 38.7 
67.2 38.4 
74.5 6o.o 
19.0 12.9 
31.6 24.3 
44.2 28.3 
65·3 31.0 
66.3 33-8 
82.3 45-3 
~ 
TABLE IX. Analysis or Variance Table, applied to sleep-time duration taken at the 
end ot righting reflex recovery. 
RIGHTING REFLEX 
Variance DF ss MS F PROBABILITY 
\....) 
\....) 
Source 
- -
Between 1 2480.62 2480.62 6.99 • 00.5 > p > • 02.5 
Within 20 7098-.59 3.54.93 
TABLE X. Statistics applied to sleep-time duration taken 
at the end of righting reflex reoover,y. 
SLEEP-TIME RIGHTING REFLEX 
~in m1nuteg} 
C57BL BALBLC 
Range 14.5-82.J 12.9-60.0 
Mean 52.9 Jl.6 
Standard 
Deviation 22.8 lJ.8 
Alpha Error .005 > p > .025 
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TABLE XI. Fall-time during the induction period, and 
anesthetic concentration at the end or the anesthesia main-
tenance period. 
FALL-TIME ANESTHETIC CONCENTRATION 
ROLL-OVER BLOOD BRAIN 
U!Lminutesl ~ mg. Ll. 0 ml. } ~ mg. L1 • 0 g.} 
C~£BL BALBLC C5£BL BALBLQ C~ZBL BALBLC 
1.5 1.? 1.28 1.53 .40 • 54 
1.4 1.4 1.39 0.98 .46 ·34 
1.2 2.1 2.50 1.05 • ?2 ·36 
1.? 1.4 1.13 1.08 
·g8 .2? 1.4 1.9 2.3? 1-92 • 1 .62 
1.4 1.1 1.89 2.56 
·53 ·55 1.3 1.? 1-55 1.39 ·5? ·52 
1., 1.3 1. ?6 0.81 
·43 • 5? 1. 1.? 1.39 o. 98 • 5 • 28 
1., 1.2 1.49 1.29 ·59 .41 1. 1.4 1.3? 1.21 ·55 • 38 
TABLE XII. Analysis of Variance Table, applied to fall-time during the anesthesia 
induction period. 
FALL-TIME 
Variance 
Source 
Between 
Within 
DF 
1 
20 
ss 
0.11 
o.sa 
MS 
0.11 
0.03 
F PROBABILITY 
3·79 .05 :=o-P > .10 
VJ 
~ 
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TABLE XIII. Statistics applied to fall-time during the 
anesthesia induction period. 
FALL-TIME ROLL-OVER 
~in minutesl 
C57BL BA.LB/C 
Range 1.2-1.7 1.1-2.1 
Mean 1.4 1.5 
Standard. 
Deviation 0.13 0.31 
Alpha Error .os >P > .10 
TABLE XIV. Analysis of Variance Table, applied to anesthetic concentration extracted 
at the end of the anesthesia maintenance period. 
BLOOD ASSAY 
Variance DF ss MS F PROBABILITY 
Source 
-
Between 1 0.50 0.50 2-20 .10 > p > ·25 
I..N 
Within 20 4.54 co 0.23 
BRAIN ASSAY 
Variance DF 55 MS F PROBABILITY 
Sour.Q.! 
- -
Between 1 4.12 4.12 3·27 .05 > p > .10 
Within 20 25.19 1.26 
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TABLE xv. Statistics applied to anesthetic concentration 
extracted at the end of the anesthesia maintenance period. 
ANESTHETIC BLOOD ASSAY BRAIN ASSAY 
CONCENTRATION ~mg.Ll.O ml.} ~mg.Ll.O gJ 
C52BL BALBLC C57BL BALBLC 
Range l.lJ-2. 50 0.81-2.56 0 .J8-0. 72 0.2?-0.62 
Mean 1.65 1-35 o.sJ 0.44 
Standard 
Deviation 0.44 o.so 0.10 0.12 
Alpha Error .10 >P >.25 .os > p > .10 
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TABLE XVI. Animal weight, brain weight, and methoxyflurane 
levels extracted per whole brain. 
Animal weifht Brain weight Anesthetic extracted (in grams ~in milligramsl ~in milligrams} 
C57BL BALBLC C5ZBL BALBLC C5ZBL BALBLC 
2.5.0 2).0 .289 ·333 .116 .180 
2.5.0 24.0 ·288 .Jll .143 ·.106 23.0 2 .o • 200 .277 .1 2 .099 
23.0 26.0 .227 .316 .086 .085 
24.0 27.0 ·236 .262 .144 .162 2 .o 24.0 .228 .276 .121 .1.52 24.0 2 .o 
.2,9 .267 .136 .139 25.0 24.0 • 2 1 .221 .127 .126 
25.0 24.0 ·330 .367 .149 .103 
25.0 24.0 • 284 ·327 .170 .144 
ll.& 24.0 ~ .:.12.2 .16Z .1 4 
Mean 24.0 2.5·0 .261 .303 .136 .130 
CHAPTER V 
DISCUSSION 
The results of this study support the findings of Kakihana 
!! ~., 1966, and Randall and Lester (1974), that genotype is 
an important determinant of response to c.N.S. depressants in 
mice. The findings of the present study, that C57BL and BALB/C 
strains awaken at different times, with similar brain and blood 
anesthetic concentrations, can be explained by two concepts. 
The first concept deals with physiological differences such as 
respiration, circulation, neurochemical substances, and meta-
bolism. These factors have general effects on the anesthetic 
process but are separate from the local actions of anesthetics 
on the central nervous system. The second concept deals spe-
cifically with brain affinity and sensitivity. 
Respiration and blood flow are two parameters which affect 
the rate of elimination of gaseous anesthetics. Any naturally 
occuring (at rest) differences in respiration and heart rates, 
between the two strains, could account for the results observed. 
Respiration was measured with one pair or mice. The C57BL mouse 
was observed to breath slightly faster (185 breaths/min.) than 
the BALB/C mouse (160 breaths/min.). Blizard and Welty (1971) 
have previously round that C57BL 1 s have faster heart rates 
than the BALB/C strain (P<.Ol). These observations are contrary 
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to the findings of the present study. It is acknowledged though, 
that no measurements were made or blood or respiratory volumes. 
There is no direct evidence that methoxyflurane affected 
circulation, respiration, or heart rate differently between 
the two strains. However, one could speculate that the sleep 
duration differences between C57BL and BALB/C mice may be at-
tributed to such factors, either local or general (Altura, 1971). 
Serotonin, a brain biogenic amine (neurochemical) as-
sociated with sleep (Mitler et !1·, 1973) has been found (in 
brain stem sections) in lesser quantities in C57BL/lOJ than 
BALB/C mice (Maas et ~., 1962; Sudak and Maas, 1964). The 
actions of serotonin are not known, but these concentration 
differences may directly or indirectly be responsible for the 
results of the present study. 
A known metabolite of methoxyflurane is fluoride (Holaday 
~ !!•, 1970). Toxic doses of fluoride cause brain excitability 
just prior to respiratory paralysis (Arena, 1970). Studies 
with rats have shown that only 1-2% of inhaled methoxyflurane is 
metabolized in 48 hours (Van Dyke et al., 1964). Although the 
possibility of metabolic differences between the strains can 
not be ignored, it should be stressed that brain and respiratory 
effects of fluoride are seen with toxic doses. In view that 
reversable anesthetic levels of methoxyflurane were used, and 
that the length of time that the mice were subjected to methoxy-
flurane was short (J5 min.), it does not seem possible that 
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increased fluoride levels could account for any differential 
affects. 
If methoxyflurane acts nonspecifically, then it is ex-
pected that the strain that sleeps longer (C57BL) should possess 
less anesthetic in the brain. As noted earlier, no intra strain 
(blood or brain) methoxyflurane differences were observed at 
the time of righting reflex recovery, even though significant 
contrast in sleep duration were recorded. Thus, the difference 
in methoxyflurane levels is either not great enough to be sig-
nificant or factors such as brain affinity or sensitivity may 
explain these results. 
Such an affinity concept can be related to methoxyflurane&' 
lipid solubility. The potency of an anesthetic, with few ex-
ceptions, is related to its' lipid solubility (Meyer, 1899; 
Overton, 1901; Bennett, 1969). Methoxyflurane with its• high 
lipid solubility, is present in large amounts, in the nerve cell 
membrane, at the end of the anesthesia maintenance period. 
Thus methoxyflurane is available in large enough quantities to 
saturate the membrane binding sites. It seems reasonable to as-
sume that species differences in membrane lipid and/or protein 
composition (membrane architecture) could cause significant var-
iations in the binding affinity of methoxyflurane - holding the 
anesthetic ror a longer time in C57BL than BALB/C mice. Anes-
thetics do bind to proteins and change their conformation (Wishia, 
1962; Wetlaufer, and Lovrien, 1964; Wetlaufer and Balasubramnian, 
1966). If protein is the main membrane unit disturbed by anes-
thetics, then differences in type and number of binding proteins, 
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could account for the sensitivity differences seen in this study. 
It should be noted though, that such a supposition could also 
be applied to any enzymatic theories of anesthesia (Q.uastel and 
Weatly, 1932; Negishi and Svaetichin, 1966; Q.uastel, 196)). 
This lack of correlation between anesthetic concentration 
and sleep duration, may also be accounted for by affinity or 
sensitivity of anesthetics to C.N.S. cardiovascular or respira-
tory centers. With inhalation anesthetics the rates of change 
of anesthetic tension in brain tissue, needed to produce anes-
thesia, is affected by respiratory volume and cardiac output 
(Wollman and Smith, 1975). Methoxyflurane at fairly low con-
centrations, affects respiration and cardiac output (CHAPTER 
II). For this reason, C57BL and BALB/C mice might have dif-
ferent cardiopulmonary sensitivities to methoxyflurane. Such 
a phenomenon could significantly affect the strains rate of 
elimination of the anesthetic; causing different sleep dura-
tions with similar brain and blood anesthetic levels at wake 
time. Other than affinity, variations in the number of neurons 
or connections in the central nervous system, could also account 
for any differences in cardiopulmonary sensitivities. 
Previous studies with alcohol (McClearn, 1962; Kakihana 
!! al., 1966) have demonstrated that BALB/C mice are more sen-
sitive to alcohol than C57BL mice. Randall and Lester (1974) 
round that C57BL/6J mice had greater sensitivity to pentobarbital 
than to alcohol, the reverse being true for the BALB/CJ mice. 
They concluded that the depressant affect of alcohol is thus 
not generalizable and that their results support the notion 
that different brain sites are involved. The results of the 
present study, gives some indication that methoxyflurane, a 
volatile anesthetic, acts at similar brain sites as pentobar-
bital, a barbiturate anesthetic. 
No fall-time (loss of righting reflex) differences were 
observed in the present study. It should be noted though, that 
the anesthetic was administered at a relatively high concentra-
tion (1.5%), which resulted in short fall-times (X- 1.45 min.), 
and that no brain anesthetic levels were taken at this time. A 
test comparing fall-time and anesthetic levels, by introducing 
the anesthetic at lower concentrations, seems important for 
future study. 
Also indicated, is a study comparing CS7BL and BALB/C's 
respiration and heart rates during anesthesia. 
Continued study should include work with membrane com-
position. An initial step in this direction would be a study 
comparing CS7BL and BALB/C's brain lipid and protein make-~p. 
Future research should also include an experiment or brain 
binding capacity. Such an experiment could by devised by: homo-
genizing brains from each strain in a dialysis bag, subject the 
brains to equal amounts of methoxyflurane, and placing the bags 
in a water bath. Comparisons could then be made of the quantity 
of methoxyflurane still bound in the brain, for each strain, for 
different lengths of time. 
It is intended that these suggested experiments will give 
some insight as to the reasons for the results seen in the 
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present study. It is acknowledged though, that critical dif-
ferences in nerve cell membrane structures, may be so subtle, 
that present technology is not available to measure significant 
differences in either brain anesthetic level, or membrane composi-
tion. 
CHAPTER VI 
SUMMARY AND CONCLUSION 
Two groups consisting of 21 each, C57BL and BALB/C 
strains of mice, were anesthesized with methoxyflurane and oxy-
gen. Two evaluations or sleep-time (pain-pressure and righting 
reflex) were compared with brain and blood anesthetic levels. 
The anesthetic levels were assayed on a gas chromatograph and 
were extracted at the beginning and the end of righting reflex 
recovery. 
1. 
4. 
5· 
The results ot this study can be summarized as follows: 
Both strains of mice lost consciousness (tall-time) at the 
same time (experiment III). 
No differences occured in blood and brain anesthetic con-
centrations, between strains, when measurements were 
made at the greatest depth of anesthesia achieved (ex-
periment III}. 
C57BL mice slept longer than BALB/C mice, when either pain 
pressure, or righting reflex evaluations of recover.y 
were used (experiment I and II). 
Pain-pressure appears to be more sensitive than righting 
reflex in evaluations of anesthetic recover,y (experi-
ment I). 
Both strains of mice awakened with equal blood and brain 
anesthetic concentrations (experiment I). 
The findings in this study support that genotype is an 
important determinant of response to c.N.S. depressants in mice. 
C57BL and BALB/C strains have demonstrated different sens1t1-
v1ties to the volatile anesthetic, methoxyflurane. These 
47 
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contrasting sensitivities may be due to differences in 
"methoxyflurane-membrane" affinities between the two strain. 
BIBLIOGRAPHY 
Abbott Laboratories: Penthrane (Methoxyflurane), Information 
Pamphlet, Printed in the U.S.A., June 1972· 
Allott, P.R., Steward, A., and Mapleson, W.W.: Determination 
of halothane in gas, blood, and tissues b,y chemical ex-
traction and gas chromatography, British Journal or Anea-
thesiologr, 4): 913, 1971. 
Altura, B.M.: Chemical and humoral regulation of blood flow 
thru the precapillary sphincter, Microvascular Research, 
3: 361, 1971. 
Anderson, N.B., Amaranath, L.: Anesthetic effect on transport 
across cell membranes, Anesthesiologz, 39: 126-152, 1973· 
Arena, J.M.: Fluoride poisoning, Poisoning: toxico!Qgz, !lmE-
~' treatments, ed., N. Kugelmass, Charles c. Thomas 
publisher, Springfield, Illinois, 1970, p.l02. 
Artusio, J.F., Poznak, A., Hunt, R.E., Tiers, R.M., and 
Alexander, M.: A clinical evaluation of methoxyflurane 
in man, Anesthesiology, 21: 512, 1960. 
Belknap, J.K., Macinnes, J.W., and McClearn, G.E.: Ethanol 
sleep times and hepatic alcohol and aldehyde dehydroge-
nase activities in mice, Pbysiologr and Behavior, 9: 
453, 1972· 
Bennett, P.B.: Inert Gas Narcosis, Ppysiolog~ ~Medicine of 
Diving, ed., P.B. Bennett and D.H. Elliot, William and 
Wilkins, Baltimore, 1969. 
Blizard, D.A., Welty, R.: Cardiac activity in the mouse: Strain 
differences, Journal Qf Comparative ~ Physiological 
Psychology, 77: 337, 1971. 
Burchfield, H.P., and Storrs, E.E.: Biochemical Applications 
of Gas Chromatograptr, New York and London, Academic Press, 
1962, p.ll8. 
Burgen, A.S.V.: Inhalation anesthesia mode of action, General 
Anesthesi~, ed., T.C. Gray & J.F. Nunn, )rd. edition, 
1971, p7428. 
49 
50 
Cale, J., Parka, R., and Jenkins, M.T.: Hepatic and renal ef-
fects of methoxyflurane, Anesthesiology, 23: 248, 1962. 
Cervenko, F.W.: Halothane in blood and tissues, Proceedings 
Royal Society £! Medicine, 61: 528, 1968. 
Chenoweth, M.B., Robertson, D.N., Erley, o.s., and Golhke, R.,: 
Blood and tissue distribution of methoxyflurane, ether 
and chloroform in the dog, Anesthesiologx, 23: 101, 1962. 
Clark, D.L., Rosner, B.S.: Neurophysiologic effects of general 
anesthetics; 1. Electroencephalogram and sensory evoked 
responses in man, Anesthesiology, 38: 564-582, 1973· 
Clements, J.A., and Wilson, K.M.: The affinity or narcotic 
agents for interfacial films, Proceedings of the National 
Academy Qf Science u.s.a., 48: {pt. 1Y: lOOB-1014, 1962. 
Cohen, E.N.: Metabolism of volatile anesthetics, Anesthesiologz, 
35: 193-202, 1971. 
Crawford, J.M.: Anesthetic agents and the chemical sensitivity 
of cortical neurons, NeuroEharmacology, 9: 31-36, 1970. 
Darbinjam, T.M., Golovchinsky, V.B., Plehotkina, S.I.: Effects 
of anesthetics on reticular and cortical activity, 
Anesthesiology, 34: 219-229, 1971. 
Davis, H.S., Collins, W.F., Randt, C.T., and Dillon, W.H.: 
Effect of anesthetic agents on evoked central nervous 
system responses, Gaseous agents, Anesthesiology, 18: 6)4, 
1957· 
Davis, H.S., Dillon, W.H., Collins, W.F., and Randt, C.T.: 
Effect of anesthetic agents on evoked central nervous system 
responses, Muscle relaxants and volatile agents, 
Anesthesiology, 19: 441, 1958. 
Eger, E.I., Lundgren, C., Miller, S.L., Stevens, w.c.: Anes-
thetic potencies of sulfur hexafluoride, carbon tetra-
chloride, chloroform, and ethrane in dogs; correlations 
with hydrate and lipid theories or anesthetic action, 
Anesthesiology, 30: 129, 1969. 
French, J.D., Vereano, M., and Magoun, H.W.: Neural basis of 
the anesthetic state, A·M·A· Archives of Neurology ~ 
Psychiatry, 69: 519-529, 1953· 
French, J.D.: Handbook of Pgysiology, American Physiological 
Society, Baltimore, Williams & Wilkins, 1960, pp. 1281-1305. 
51 
Gergis, S.D., Dretchen, K.L.: Effects of anesthetics on acetyl-
choline released from myoneural junction, Socief* fo6 
Experimental Biology ~ Medicine P.roceed1ngs,l: 29-635, 
1972. 
Goth, A.: Medical Pharmacology: principle~ and concepts, C.V. 
Mosby Company, Saint Louis, 1974. 
Guedel, A.E.: Inhalation Anesthesia, The MacMillan Company, 
New York, 1937, p. 15. 
Halevy, s., Frumin, M.J., Rosenthal, s., and Levine, W.G.: 
Brain disposition, liver metabolism, and behavioral re-
sponses to barbiturates in inbred "sensitive• and Mre-
sistant" mice, British Journal 2! Anesthesia, 46: 43, 1974. 
Halsey, M.J., Sawyer, D.V.M., Eger, E.I., Bahlman, S.H., and 
Impelman, D.M.K.: Hepatic metabolism of halothane, methoxy-
flurane, cyclopropane, ethrane4 and forane in miniature swine, Anesthesiology, 35: 43- 7, 1971. 
Harvey, S.C.: Hypnotics and Sedatives, The Pharmacological ~is 
of Therapeutics, ed. by L.S. Goodman and A. Gilman, 
MacMillan PUblishing Company, New York, 1975. 
Holaday, D.A.: Metabolic production of toxic substances follow-
ing general anesthesia, Confer~ 2n CellYl!£ ToxicitY 
of Anesthetics, Seattle, 1970. 
Jay, G.E.: Variation in responses of various mouse strains to 
hexabarbital (Evipal), froceedings Q! the Societl ~ 
Experimental Biolo~ ~ Medicine, 90: 378, 1955· 
Jori, A., Bianohetti, A., and Prestini, P.E.: Relations between 
barbiturate brain levels and sleeping time in various 
experimental conditions, Biochemical Pharmacology, 19: 
2687, 1970. 
Junes, M.G., and Siebecker, K.L.: Hepatic and respiratory effects 
of methoxyflurane, ~raduat~ Assembly ln Anesthesiology, 
New York, December, 1960. 
Kakihana, R.Y., Brown, D.R., McClearn, G.E., and Tabershaw, I.: 
Brain sensitivity to alcohol in inbred mouse strains, 
Science (Wash.), 154: 1574, 1966. 
Karis, J.H., Gl1ssen, A.J., Nastuk, W.L.: Mode of action of 
di-ethyl ether in blocking neuromuscular transmission, 
Anesthesiology, 27: 42, 1966. 
I 
52 
Karis, J.H., Glissen, A.J., and Nastuk, W.L.: The effects of 
volatile anesthetics on neuromuscular transmission, 
AnesthesiologY, 28: 128-134, 1967. 
Knox, P.R., Stephen, C.R., and North, W.G.: Methoxyflurane 
clinical evaluation, AnesthesiologY, 23: 238, 1962. 
Krantz, J.C., Jr., Esquibel, A., Truit, E.B., Jr., Ling, A.S.C., 
and Kurland, A.A.: Hexafluorodiethyl ether (INDOKLON) -
an inhalant convulsant: its use in psychiatric treatment, 
Journal of the American Medical Association, 166: 1555-
1562, l95g.---
Larrabee, M.G., and Posternak, J.M.: Selective action of anes-
thetics on synapses and axone in mammalian sympathetic 
ganglia, Journal of Neuropbysiologz, 15: 91-97, 1952· 
Lindsey, D.B., Bowden, J., and Magoun, H.W.: Effect upon EEG of 
acute injur,y to brain stem activating system, Electroen-
cephalogical ~ Clinical Neurophysiology, 1: 475, 1949. 
Maas, J.: Neurochemical differences between two strains of 
mice, Science, 137: 621, 1962. 
Mazze, R.I., Shue, G.L., Jackson, S.H.: Renal dysfunction 
associated with methoxyflurane anesthesia, Journal 2f 
the American Medical Association, 216: 278-288, 1971. 
McClearn, G.E.: Genetic differences in the effect of alcohol 
upon behavior in mice, Alcohol~ Road Traffic, ed. J.D. 
Havard, British Medical Association, London, 1962. 
Meyer, H.: Zur Theorie der Alkoholnarkose. Welche Eigensohaft 
der Anaesthetika bedingt ihre narkotishe Wirkung? Archives 
21 Experimental Pathologr ~ Pharmakology, 42: 109, 1899. 
Michenfelder, V.D., Van D,yke, R.A., and Theye, R.A.: The effects 
ot anesthetic agents and techniques on canine cerebral ATP 
and lactate levels, ~nesthesiology, 33: 315, 1970. 
Miller, S.L.: A theory of gaseous anesthetics1 Proceedings 2f 
the National AcademY Q! Science Q·~·~·· ~7: 1515, 1961. 
Mitler, M.M., Cohen, H.B., Gratten, J., Dominic, J., Deguchi, T., 
Barchas, J.D., Dement, W.o., and Kessler, B.: Sleep and 
Serotonin in two strains of Mus musculus, Pharmacologz, 
Biochemistry, and Behavior, 1(5): 501, 1973· 
53 
Mori, K., Winters, W.D., Spooner, C.E.: Comparison or reticular 
and cochlear multiple unit activity with auditory evoked 
responses during various stages induced by anesthetic 
agents, ElectroenceShalo~ical Clinical Neurophysiological 
Studies, 24: 242-24 I 19 8. 
Moruzzi, G., and Magoun, H.W.: Brainstem reticular formation 
and activation or EEG, Electroencephalogical !nS Clinical 
Neurophysiology, 1: 455, 1949. 
Mullins, L.J.: Anesthetics, Handbook of NeurochemistrY, ed. 
A. Lajtha, 1971, vol. 6, pp. 385=421. 
Negishi, K., and Svaetichin, G.: Effects of alcohols and volatile 
anesthetics on S-potential producing cells and neurons, 
Pfluger Archives Gee. Physiology, 292: 218-228, 1966. 
Noordhoek, J.: Pharmacokinetics and dose-sleeping time lines 
of hexobarbital in mice, European Journal Q! PharmacologY, 
3= 242, 1968. 
North, K.D.: Methoxyflurane, effects on dogs and monkeys, 
Anesthesiology, 23: 315, 1961. 
Nunn, J.F.: Anesthesia and the Living Cell: Specificity of 
Action, Acta Anaeathesiologica Scandinavica, 16: 169-175, 
1972· 
Overton, E.: Studien uber die Narkose, zugleich ein Beitrag 
zur allgemeinen Pharmakologie, Jena, Q. Fisher, 1901. 
Pauling, L.: A molecular theory or general anesthetics, 
Science, 134: 15-21, 1961. 
Price, H.L.: General Anesthetics,~ Pharmacological Basis 
2f Therapeuticf, ed. by L.S. Goodman and A. Gilman, 
New York, 1975· 
Quastel, K.M.: Effects of drugs on metabolism or the brain !n 
vitro, British Medical Bulletin, 21: 49-56, 1965. 
Quastel, J.H., and Wheatley, A.H.M.: Narcosis and oxidations, 
~rooeedings Q! ~Royal Society, London, S,B., 112: 
0, 1932. 
Randall, C.L., and Lester, D.: Differential effects of ethanol 
and pentobarbital on sleep time in C57BL and BALB mice, 
Journal 2f Pharmacology ~ Experimental Therapeutics, 
188: 27-33, 1974. 
Richens, A.: Microelectrode studies in the frog isolated spinal 
cord during depression by general anesthetic agents, British 
Journal Qf Pharmacology, 36: 312, 1969. 
Rogers, D.A., McClearn, G.E., Bennett, E.L., and Hebert, M.: 
Alcohol preference as a function of its caloric utility 
in mice, Journal of Comparative and Physiology Psychology, 
56: 666-672,-r9b3-
Schlesinger, K.: Genetics and biochemical correlations of alcohol 
preference in mice, American Journal of Psychiatry, 122: 
767-773, 1966. 
Seeman, P.: The membrane actions of anesthetics and tranquilizere, 
Pharmacological Reviews, 24: 583-655, 1972. 
Seeman, P., Kwant, W.o., Sauks, T.: Membrane expansion of ery-
throcyte ghosts by tranquilizers and anesthetics, Biochimica 
et Bioppysica Acta, 183: 499, 1969. 
Seeman, P., and Roth, s.: General anesthetics expand cell mem-
branes at surgical concentrations, Biochimica !1 Biopbysica 
Acta, 255: 171-177, 1972. 
Sonnenehein, R.R., Jamison, R., Loveseth, L.J., Cassels, H., 
and Ivy, A.C.: A study on the mechanism of nitrous oxide 
analgesia, Journal of Applied Physiology, 1: 254, 1948. 
Speciale, S.G., and Friedman, A.H.: Melatonin potentiation of 
pentobarbital induced sleep as a function of the time or 
day, Federation Proceedings, 30: 1096, abe., 1971. 
Sudak, H., and Maas, J.: Central nervous system serotonin and 
norepinephrin localization in emotional and non-emotional 
strains of mice, Nature, 203: 1254, 1964. 
Tabakoff, B., and Erwin, V.G.: Differences in C.N.S. metabolism 
and duration of pentobarbital anesthesia in two inbred 
strains, Federation ProceedingsL 30: 1097, abe., 1971. 
Van Dyke, R.A., Chenoweth, M.B., and Poznak, A.V.: Metabolism 
of volatile anesthetics - I, Biochemical Pharmacology, 
13: 1239-1247, 1964. 
Weakly, J.N.: Effect of barbiturates on 11 quantal" synaptic 
transmission in spinal motorneurone, Journal 2! Ppysiologl 
(London), 204: 63, 1969. 
' 
55 
Wetlaufer, D.B., and Balasubramanian, D.: Reversible alteration 
or the structure or globular proteins by anesthetic agents, 
Proceedings of the National Academy gf Science, g.§.A., 
55: 762, 196b7 
Wetlaufer, D.B., and Lovrien, R.: Induction of reversible struc-
tural changes in proteins by nonpolar substances, Journal 
or Biological Chemistry, 239: 596, 1964. 
Wishnia, A.: The solubility of hydrocarbons (gases) in protein 
solutions, National Academy Qf Science, Proceedings, 48: 
2200, 1962. 
Wolfson, B., Ciccarelli, H.E., and Siker, E.s.: Gas Chromato-
graphy using an internal standard for the estimation or 
methoxyflurane levels in blood, British Journal ~ 
Anesthesiologl, 38: 29, 1966. 
Wollman, H., and Smith, T.C.: Uptake, Distribution, Elimination, 
and Administration or inhalational anesthetics, The 
Pharmacological ~is 2! !herapeutics, ed. by L.~Goodman 
and A. Gilman, New York, 1975· 
Wood-Smith, F.G., Vickers, M.D., and Stewart, H.c.: Drugs 1n 
Anesthetic Practice, London, England, Butterworth & Company, 
1973, p. 166. 
APPENDIX 
Figure I· 
CI:romatogram of dose response solutions of methoxyflurane 
(1.: & m) in water (w· & w), and column residue (toluene) ( T 
& t) fror.1 brain calibrating solution. J.Iethoxyflurane con-
centrations are 40 milligram percent (H) and 20 milligrc:un 
percent (m). G.c. settings: column temperature 90° C., 
nitrogen flot'l setting 1.5, range 10, attenuation 16, paper 
speed 0.5 inch per minute. Sample size 0.5 microliter. 
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Figure II 
Chro;natogram of calibrating solution of methoxyflurane (N) 
and di-ethyl ether (E) {interne.l standard) in toluene(T). 
Methoxyflurane concentration equals 8.0 milligram percent. 
G.C. settings: column temperature 100° C., nitrogen flmv 
setting 1.0, range 10, attenuation 16, paper speed 0.5 
inch per minute. Sample size 0.5 microliter (approximately). 
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Chromatogram of blood data from experiment I. Note the 
variances in the methoxyflurane (1-1) peak heights (8.5, 
10.0, 14.0) between the injections. G.C •. settings: column 
temperature 90° C., nitrogen flow setting 1.5, range 10, 
attenuation 16, paper speed 0.5 inch per minute. Sample 
size 0.5 microliter. 
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Figu.re IV 
c:1roma tos-ran of blood data from experiment III. Note the 
uniformity in the methoxyfluro.ne (N) peak heights bet11een 
the injections of each strain. G.C. settings: column tem-
perature 100° C., nitrogen flow setting 1.0, range 10, at-
tenuation 16, paper speed 0.5 inch per minute. Srunple size 
0.5 microliter. 
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Figure V 
Chro:natogrem representing bl.,ain anesthetic extractions of 
experiments I and III. Note the uniformity in the di-ethyl 
ether (E)/ methoxyflurane (M) ratio between the lnjocttono 
of each strain. G.C. settings: column temperature 100° C., 
nitrogen flovr setting 1.0, range 10, attenuation 16, paper 
speed 0.5 inch per ~inute. Sample size 0.5 microliter (approx.). 
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Materials: 
This study utilized the following materials: 
42 male mice (10-13-week-old, 22-30 grams) 
21 C57BL 
21 BALB/C 
Methoxyflurane (375 ml.) 
Oxygen (8 E-tanks) 
Eight 3-milliliter glass vials 
Four 1-mi1liliter glass vials 
One Erlenmeyer flask - 250 ml. (holding tank) 
Three Erlenmeyer flasks - 500 ml. 
Bell jar - 10.4 liters 
2' x 2 1 by 3/4u plywood (base) 
Three no• 7 & one no. 5 rubber stoppers 
Seven glass tubes - 6u each 
Plastic tubing 12' 
Heparized capillar,y tubes (150) 
Seal-ease clay sealer - 1 tray 
Aluminum foil - 2 sq. feet 
Four G.C. septums 
Glass beads 
Extraction solution: 
Toluene - 200 ml. 
Di-ethyl ether- 1.6 microliter (ul.) 
Calibrating solution: 
Brain (Exp. I & III) 
Extracting solution - 25 ml. 
Methoxyflurane- 1.75 ul., or 2.45 mg. {10 mg. percent) 
Blood (Exp. I) 
Distilled water lOml., methoxyflurane 2.8 ul. (40 mg. %) 
Distilled water lOml., methoxyflurane 1.4 ul. (20 mg. %) 
Blood (Exp. III) 
Extracting solution - 25 ml. 
Methoxyflurane - 1.7; ul. or 2.4; mg. (10 mg. %) 
This study utilized the following equipment: 
Oxygen liter-flow gas regulator 
Vaporizer, Pentec I (1.; %maximum output) 
Disection kit 
Centrifuge (3000 r.p.m.) 
Vortex mixer 
Mechanical mixer 
One 1-microliter glass syringe (Hamilton Company) 
Gas Chromatograph (Hewlett-Packard Series 5750B) 
Gas Chromatograph columns (LABCO INC., Connecticut) 
Electric timer 
Micro-capillary centrifuge (I.E.c. model MB) 
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